Recombinant tissue plasminogen activator prevents intimal hyperplasia after balloon angioplasty in hypercholesterolemic rabbits

Japanese Circulation Journal

Volumn 60, Issue 11, 1996, Pages 889-894

  Kanamasa, Ken ^a   Ishida, Norihiro ^a   Kato, Hisaharu ^a   Sakamoto, Shigeru ^a   Nakabayashi, Takayuki ^a   Otani, Narutaka ^a   Ishikawa, Kinji ^a   Katori, Ryo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioplasty; Growth factor; Intimal hyperplasia; PCNA; Restenosis; tPA

Indexed keywords

ALTEPLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL DIAMETER; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RABBIT;

ANGIOPLASTY, BALLOON; ANIMALS; FEMALE; HYPERCHOLESTEROLEMIA; HYPERPLASIA; INFUSIONS, PARENTERAL; MALE; PLASMINOGEN ACTIVATORS; RABBITS; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TUNICA INTIMA;

EID: 0029826015     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.60.889     Document Type: Article

References (22)

1. Mizuno K, Miyamoto A, Sakurada M, Yanagida Y, Satomura K, Shibuya T, et al: Evaluation of coronary thrombi after PTCA by angioscope (abstract). Circulation 1989; 80: 11-523
2. Uchida Y, Hasegawa K, Kawahara K, Shibuya I: Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplasty. Am Heart J 1989; 117: 769-776
3. Itoh A, Miyazaki S, Nonogi H, Daikoku S, Haze K: Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty: Significance of yellow plaque. Circulation 1995; 91: 1389-1396
4. Forrester JS, Fishbein M, Helfant R, Fagin J: A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J Am Coll Cardiol 1991; 17: 758-769
5. Schwartz RS, Holmes DR Jr, Topol EJ: The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-1293
6. Gellman J, Sigal SL, Chen Q, Esquivel EL, Ezekowitz MD: The effect of tPA on restenosis following balloon angioplasty: a study in the atherosclerotic rabbit (abstract). J Am Coll Cardiol 1991; 17: 25A
7. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, et al: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162: 285-294
8. Sato Y, Rifkin DB: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol 1989; 109: 309-315
9. Kojima S, Harpel PC, Rifkin DB: Lipoprotein(a) inhibits the generation of transforming growth factor β. An endogenous inhibitor of smooth muscle cell migration. J Cell Biol 1991; 113; 1439-1445
10. Hajjar KA: The endothelial cell tissue plasminogen activator receptor. J Biol Chem 1991; 266: 21962-21970
11. Sawa H, Sobel BE, Fujii S: Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury. Circ Res 1993; 73: 671-680
12. Jackson CL, Reidy MA: The role of plasminogen activation in smooth muscle cell migration after arterial injury. In Brakman P, Kluft C, editors. Plasminogen activation in fibrinolysis, in tissue remodeling, and in development. New York, The New York Academy of Sciences 1992; 667: 141-162
13. Schwartz L, Lesperance J, Bourassa MG, Eastwood C, Kazim F, Arafah M, et al: The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty. Am Heart J 1990; 119: 232-236
14. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III: Effect of 18- to 24 h heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117: 777-782
15. Faxon DP, Spiro TE, Minor S, Coté G, Douglas J, Gottlieb R, et al: Low molecular weight heparin in prevention of restenosis after angioplasty. Results of enoxaparin restenosis (ERA) trial. Circulation 1994; 90: 908-914
16. Gimple LW, Gertz SD, Haber HL, Ragosta M, Powers ER, Roberts WC, et al: Effects of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits: A quantitative angiographic and histopathological study. Circulation 1992; 86: 1536-1546.
17. Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V: Effects of thrombin inhibition on the development of acute platelet-thrombin deposition during angioplasty in pigs. Circulation 1989; 79: 657-665
18. Lopez-Sendon J, Sobrino N, Gamallo C, Lorenzo A, Jimenez J, Fantidis P, et al: Locally delivered heparin reduces intimai hyperplasia and lumen stenosis following balloon injury in swine. Circulation 1993; 88: I-197
19. Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, et al: Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GP IIb/IIIa receptor antagonist. Circulation 1994; 89: 3-12
20. Philips DR, Charo IF, Scarborough RM: GP IIb/IIIa: The responsive integrin. Cell 1991; 65: 359-362
21. Meyer BJ, Fernández-Ortiz A, Mailhac A, Falk E, Badimon L, Michael AD, et al: Local delivery of r-Hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 1994; 90: 2474-2480
22. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, et al: Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at 6 months. Lancet 1994; 343: 881-886